The life science industry is projected to maintain high growth due to the rapid graying of society. By 2018, the population of people aged 65 and over is expected to reach 10% in the world, 25% in Japan, 20% in Western Europe, and 10% even in China.
In line with the progress of gene analysis, preventive medicine to understand when and how incident risk increases has been adopted and is expected to be applied in various ways. As a result, human life expectancy is increasing gradually and the percentage of research and development (R&D) cost in the life science industry is increasing annually both in Japan and abroad. This trend is expected to continue in the future.
In addition to providing accounting audit and financial advisory services, we at BDO Toyo & Co. will provide a wide range of services according to client needs including professional consulting by leveraging our group's extensive knowledge and expertise in life sciences.